Relevant bibliographies by topics / H. pylori therapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'H. pylori therapy'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'H. pylori therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "H. pylori therapy"

1

I.M., Saracino, Pavoni M., Zullo A., et al. "Antibiotic Resistance and Therapy Outcome in H. pylori Eradication Failure Patients." Antibiotics 9, no. 3 (2020): 121. http://dx.doi.org/10.3390/antibiotics9030121.

Full text
Abstract:
Helicobacter pylori (H. pylori) eradication fails in a definite amount of patients despite one or more therapeutic attempts. Curing these patients is progressively more difficult, due to development of antibiotic resistance. Current guidelines suggest testing antibiotic susceptibility in H. pylori isolates following two therapeutic attempts. Aim: to evaluate the development of antibiotic resistance, MIC values trends and therapeutic outcomes in patients who failed at least one H. pylori eradication therapy. Methods: consecutive patients, referred to perform upper gastrointestinal endoscopy (UG
APA, Harvard, Vancouver, ISO, and other styles
2

Fiorini, Giulia, Ilaria Maria Saracino, Angelo Zullo, et al. "Antibiotic Resistance and Therapy for H. pylori Infection in Immigrant Patients Treated in Italy." Journal of Clinical Medicine 9, no. 5 (2020): 1299. http://dx.doi.org/10.3390/jcm9051299.

Full text
Abstract:
Background: Helicobacter pylori (H. pylori) infection is the leading cause of both peptic ulcers and gastric tumors, including low-grade MALT-lymphoma and adenocarcinoma. Although it is decreasing in developed countries, H. pylori prevalence remains high in developing areas, mainly due to low socio-economic levels, and the potential consumption of contaminated water. Moreover, a different pattern of primary antibiotic resistance is expected in their H. pylori isolates, potentially affecting the efficacy of standard eradication therapies. Indeed, a previous study showed the eradication rate fol
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Anti-H. pylori therapy." Inpharma Weekly &NA;, no. 1148 (1998): 13. http://dx.doi.org/10.2165/00128413-199811480-00023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Di Ciaula, Agostino, Giuseppe Scaccianoce, Marino Venerito, et al. "Eradication Rates in Italian Subjects Heterogeneously Managed for Helicobacter pylori Infection. Time to Abandon Empiric Treatments in Southern Europe." Journal of Gastrointestinal and Liver Diseases 26, no. 2 (2017): 129–37. http://dx.doi.org/10.15403/jgld.2014.1121.262.itl.

Full text
Abstract:
Background & Aims: H. pylori eradication is strongly affected by various factors, including the ongoing antibiotic resistance. We describe a “real life” scenario in patients managed for H. pylori-related conditions, living in a southern Italian region (Apulia), an area with clarithromycin resistance >15%.Methods: 2,224 subjects were studied in two tertiary referral centers in Apulia. Analyses included: reason for referral, H. pylori infection rates (13C-urea breath test – UBT or upper endoscopy), and eradication rates following distinct regimens previously prescribed or prospectively pr
APA, Harvard, Vancouver, ISO, and other styles
5

Zullo, Angelo, Vincenzo De Francesco, Annamaria Bellesia, et al. "Bismuth-based Quadruple Therapy Following H. pylori Eradication Failures: a Multicenter Study in Clinical Practice." Journal of Gastrointestinal and Liver Diseases 26, no. 3 (2017): 225–29. http://dx.doi.org/10.15403/jgld.2014.1121.263.zul.

Full text
Abstract:
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in these patients managed in clinical practice.
 Methods: This was a prospective, open-label, multicenter study enrolling consecutive, adult patients with persistent H. pylori infection following at least one standard therapy. All patients received a rescue quadruple therapy with Pylera (3 capsules four times daily) and esomeprazole 20 mg (1
APA, Harvard, Vancouver, ISO, and other styles
6

Hartanto, Darius. "Helicobacter pylori Infection: Diagnosis and Therapy." Asian Journal of Medical Sciences 12, no. 4 (2021): 145–48. http://dx.doi.org/10.3126/ajms.v12i4.34506.

Full text
Abstract:
Helicobacter pylori (H. pylori) is a spiral shape gram-negative bacillus and have flagella for motility in mucus environment. H. pylori is microaerophilic organism, slow growing and requires complex growth media in vitro. H. pylori infecting more than 50% populations in worldwide. Prevalence of H. pylori infection is higher in developing countries compared to developed one, and indicates that socioeconomic and living standard may play a major role in the distribution. This study aims to provide an overview of how to diagnose and manage Helicobacter pylori infection. This study reviewed various
APA, Harvard, Vancouver, ISO, and other styles
7

Darius Hartanto. "Helicobacter pylori Infection: Diagnosis and Therapy." Asian Journal of Medical Sciences 12, no. 4 (2021): 145–48. https://doi.org/10.71152/ajms.v12i4.3582.

Full text
Abstract:
Helicobacter pylori (H. pylori) is a spiral shape gram-negative bacillus and have flagella for motility in mucus environment. H. pylori is microaerophilic organism, slow growing and requires complex growth media in vitro. H. pylori infecting more than 50% populations in worldwide. Prevalence of H. pylori infection is higher in developing countries compared to developed one, and indicates that socioeconomic and living standard may play a major role in the distribution. This study aims to provide an overview of how to diagnose and manage Helicobacter pylori infection. This study reviewed various
APA, Harvard, Vancouver, ISO, and other styles
8

Eissa, Adil, and Saad Mirza. "The Relevance of Helicobacter pylori Infection to Iron Deficiency Anemia in Duhok City." Iraqi Journal of Medical Sciences 19, no. 1 (2021): 33–38. http://dx.doi.org/10.22578/ijms.19.1.5.

Full text
Abstract:
Background:Helicobacter pylori (H. pylori) infection had been criticized for many deleterious effects and had been amalgamated to iron deficiency by many authors, frequently based on correlative rather than direct relationship studies and often opposed by others. Objective: To evaluate the role of H. pylori infection in the etiology of iron deficiency anemia and to study the impact of the bacterial eradication on the response to iron therapy. Methods:The current study represents an interventional prospective study and involved 52 non-pregnant females with iron deficiency anemia. All patients w
APA, Harvard, Vancouver, ISO, and other styles
9

De Francesco, Vincenzo, Angelo Zullo, Luigi Gatta, et al. "Rescue Therapies for H. pylori Infection in Italy." Antibiotics 10, no. 5 (2021): 525. http://dx.doi.org/10.3390/antibiotics10050525.

Full text
Abstract:
Background/Aims: Curing Helicobacter pylori infection remains challenging for clinicians, as no proposed first-line therapy achieves bacterial eradication in all treated patients so that several patients need two or more consecutive treatments. Bacterial culture with antibiotics susceptibility testing is largely unachievable in Italy, and empiric second-line and rescue therapies are generally used. This study aimed to identify what eradication regimens perform better in Italy, following first-line therapy failure. Methods: We performed a literature search on PubMed for studies on standard ther
APA, Harvard, Vancouver, ISO, and other styles
10

Tongtawee, Taweesak, Wareeporn Wattanawongdon, and Theeraya Simawaranon. "Effects of periodontal therapy on eradication and recurrence of Helicobacter pylori infection after successful treatment." Journal of International Medical Research 47, no. 2 (2019): 875–83. http://dx.doi.org/10.1177/0300060518816158.

Full text
Abstract:
Objectives This study aimed to evaluate the effects of periodontal therapy on the efficacy of Helicobacter pylori eradication and on the recurrence of infection after eradication. Methods We conducted a prospective randomized trial on 698 gastric H. pylori-infected patients, of whom 347 received gastric H. pylori treatment alone and 342 received gastric H. pylori treatment plus periodontal therapy. The presence of H. pylori and associated virulence genes were detected by real-time polymerase chain reaction. Results After eradication of gastric H. pylori infection, the recurrence of gastric H.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "H. pylori therapy"

1

You, Shih-Lin, and 游士璘. "Cost-effectiveness Analysis of Empirical Eradication Therapy of H. pylori." Thesis, 2007. http://ndltd.ncl.edu.tw/handle/95080065683669343116.

Full text
Abstract:
碩士<br>高雄醫學大學<br>臨床藥學研究所碩士班<br>95<br>The aim of this study was to compare the cost-effectiveness of the “empirical eradication” strategy of H. pylori and the “traditional” strategy in patients with active non-complicated peptic ulcer disease over a period of one year. The numerous evidences have assessed the role of Helicobacter pylori (H. pylori) in the pathogenesis of gastric ulcers and duodenal ulcers. And there is a great decrease of ulcer recurrence after H. pylori eradication from 67% to 6% and 59% to 4% in patients with duodenal ulcers and gastric ulcers, respectively. Additionally, th
APA, Harvard, Vancouver, ISO, and other styles
2

Jin, Chuan. "Improvement of adoptive T-cell therapy for Cancer." Doctoral thesis, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-300210.

Full text
Abstract:
Cancer immunotherapy has recently made remarkable clinical progress. Adoptive transfer of T-cells engineered with a chimeric antigen receptor (CAR) against CD19 has been successful in treatment of B-cell leukemia. Patient’s T-cells are isolated, activated, transduced with a vector encoding the CAR molecule and then expanded before being transferred back to the patient. However some obstacles restrict its success in solid tumors. This thesis explores different aspects to improve CAR T-cells therapy of cancer. Ex vivo expanded T-cells are usually sensitive to the harsh tumor microenvironment aft
APA, Harvard, Vancouver, ISO, and other styles
3

Baumann, Nicola. "Diagnostische Nachweisverfahren für Helicobacter pylori im Vergleich: Prospektive Untersuchung bei 132 Patienten der Universitätsmedizin Göttingen." Doctoral thesis, 2012. http://hdl.handle.net/11858/00-1735-0000-000D-F02F-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "H. pylori therapy"

1

Furuta, Takahisa, Mitsushige Sugimoto, Mihoko Yamade, et al. "Personalized Therapy in H. pylori Eradication." In Helicobacter pylori. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55705-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Malfertheiner, P., U. Peitz, and G. Treiber. "What constitutes failure of H. pylori eradication therapy?" In Helicobactor pylori. Springer Netherlands, 2003. http://dx.doi.org/10.1007/978-94-017-1763-2_41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Singh, Prabhakar, Shree Prakash Tiwari, Mohammad Murtaza Mehdi, and Rajesh Sharma. "Role of Bacterial Infection (H. pylori) in Colon Carcinogenesis and Therapeutic Approaches." In Colon Cancer Diagnosis and Therapy. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-64668-4_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Aanniz, Tarik, Wissal Bakri, Safae El Mazouri, et al. "Biofilm and Quorum Sensing in Helicobacter pylori." In Bacterial Biofilms [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.104568.

Full text
Abstract:
Helicobacter pylori (H. pylori) is a gram-negative bacterium living in the human gastrointestinal tract considered as the most common cause of gastritis. H. pylori was listed as the main risk factor for gastric cancer. Triple therapy consisting of a proton pump inhibitor and combinations of antibiotics is the main treatment used. However, this line of therapy has proven less effective mainly due to biofilm formation. Bacteria can regulate and synchronize the expression of multiple genes involved in virulence, toxin production, motility, chemotaxis, and biofilm formation by quorum sensing (QS),
APA, Harvard, Vancouver, ISO, and other styles
5

"Helicobacter Pylori (H. Pylori) Infection." In The APRN and PA’s Complete Guide to Prescribing Drug Therapy. Springer Publishing Company, 2019. http://dx.doi.org/10.1891/9780826179340.0164.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Helicobacter Pylori (H. Pylori) Infection." In The APRN and PA’s Complete Guide to Prescribing Drug Therapy. Springer Publishing Company, 2019. http://dx.doi.org/10.1891/9780826179357.0164.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhou, Xiao-Ying, Guo-Xin Zhang, Joy Qing-Jiao Liao, and Harry Hua-Xiang Xia. "Rapid Non-invasive Techniques for Detecting Antibiotic Resistance in Helicobacter pylori: An Update and Clinical Applications." In Towards the Eradication of <i>Helicobacter pylori</i> Infection - Rapid Diagnosis and Precision Treatment [Working Title]. IntechOpen, 2024. http://dx.doi.org/10.5772/intechopen.1005256.

Full text
Abstract:
The global prevalence of Helicobacter pylori infection remains high, posing a significant health challenge worldwide. The efficacy of anti-H. pylori antibiotic-based regimens is compromised by the increasing antibiotic resistance in H. pylori. Thus, it is important to detect antibiotic resistance in H. pylori to ensure appropriate and effective treatment strategies. Currently, conventional culture-based methods are used for detecting antibiotic resistance (so-called phenotypic resistance) in H. pylori, but these methods are tedious and time-consuming (at least 72 h) and rely on the successful
APA, Harvard, Vancouver, ISO, and other styles
8

Martins, Fellipe Watanabe, and Ethel Zimberg Chehter. "THE EFFECTS OF HELICOBACTER PYLORI ERADICATION THERAPY ON THE INCIDENCE OF GASTRIC ADENOCARCINOMA." In Multidisciplinary Research and Practice. Seven Editora, 2024. http://dx.doi.org/10.56238/sevened2024.029-057.

Full text
Abstract:
INTRODUCTION: Helicobacter pylori is the major risk factor for the development of gastric adenocarcinoma, and may increase its risk by two times. Thus, in the last twenty years, many studies have investigated whether eradicating this agent reduces the risk of gastric cancer. However, the results were initially inconsistent. Therefore, this systematic review was carried out to identify the impact of H. pylori eradication on the incidence of gastric adenocarcinoma. METHOD: Using the Pubmed, Cochrane, Medline, and LILACS databases, a systematic review of studies involving H. pylori eradication tr
APA, Harvard, Vancouver, ISO, and other styles
9

Berzin, Tyler M., and Kenneth R. Falchuk. "Peptic Ulcer Disease." In The Brigham Intensive Review of Internal Medicine. Oxford University Press, 2014. http://dx.doi.org/10.1093/med/9780199358274.003.0069.

Full text
Abstract:
Peptic ulcer disease (PUD) involves the stomach or duodenum and is a significant cause of morbidity and mortality both in the United States and worldwide, with a lifetime prevalence estimated at 5–15%. For a good part of the 20th century PUD was felt to be a condition related to stress and dietary factors. More recently, our understanding of PUD has been advanced by research into the role of gastric acid secretion and the benefits of various classes of antisecretory medications and, perhaps most importantly, in 1984, by Warren and Marshall, who identified Helicobacter pylori (H. pylori) as a p
APA, Harvard, Vancouver, ISO, and other styles
10

YUAN, Y. "Treatment of non-NSAID and non-H. pylori gastroduodenal ulcers and hypersecretory states." In Therapy of Digestive Disorders. Elsevier, 2006. http://dx.doi.org/10.1016/b978-1-4160-0317-5.50026-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "H. pylori therapy"

1

Park, E. "Comparison of standard, sequential, and concomitant first line eradication therapy for H. pylori." In 51. Jahrestagung & 29. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH). Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1654628.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'H. pylori therapy' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography